scispace - formally typeset
E

Einav Tayeb-Fligelman

Researcher at Technion – Israel Institute of Technology

Publications -  18
Citations -  622

Einav Tayeb-Fligelman is an academic researcher from Technion – Israel Institute of Technology. The author has contributed to research in topics: Fibril & Amyloid. The author has an hindex of 8, co-authored 17 publications receiving 404 citations. Previous affiliations of Einav Tayeb-Fligelman include University of California, Los Angeles & Howard Hughes Medical Institute.

Papers
More filters
Journal ArticleDOI

The cytotoxic Staphylococcus aureus PSMα3 reveals a cross-α amyloid-like fibril

TL;DR: The fibril structure and function of the highly toxic, 22-residue phenol-soluble modulin α3 (PSMα3) peptide secreted by Staphylococcus aureus is determined and a distinctive “cross-α” amyloid-like architecture is revealed, in which amphipathic α helices stacked perpendicular to the fibrIL axis into tight self-associating sheets.
Journal ArticleDOI

Structural Insights into Curli CsgA Cross-β Fibril Architecture Inspire Repurposing of Anti-amyloid Compounds as Anti-biofilm Agents.

TL;DR: Crystal structures of amyloid-forming segments from the major curli subunit, CsgA, are presented, revealing steric zipper fibrils of tightly mated β-sheets, demonstrating a structural link between curli and human pathological amyloids.
Journal ArticleDOI

Staphylococcus aureus PSMα3 Cross-α Fibril Polymorphism and Determinants of Cytotoxicity.

TL;DR: It is demonstrated that massive T cell deformation and death are linked with PSM α3 aggregation and co-localization with cell membranes, and hypothesize that PSMα3 cytotoxicity is governed by the ability to form cross-α fibrils and involves a dynamic process of co-aggregation with the cell membrane, rupturing it.